Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nimodipine Oral Solution

Approval Number

国药准字H20244290

Company成都倍特得诺药业有限公司

Registration Date

June 28, 2024

Drug Information

Generic Name

尼莫地平口服溶液

Dosage Form

口服溶液剂

Strength

237ml：1.422g

Drug Type

化学药品

Registration Date

June 28, 2024

Company Information

Applicant Company

Company Name成都倍特得诺药业有限公司

Company Address

成都市温江区成都海峡两岸科技产业开发园科林路西段66号

Manufacturing Company

Company Name成都倍特得诺药业有限公司

Company Address

成都市温江区成都海峡两岸科技产业开发园区科林路西段

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

尼莫地平口服溶液 - NMPA 批准文号 | MedPath